Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Regarding S&L

Regarding S&L

posted on Jun 19, 2007 04:29PM

Reposting a question I listed at the end of previous post:

Considering S&L are each a 9.99% holder of PTSC, aren't all of their share sales subject to reporting requirement thru the Beneficial Ownership requirements (I believe anyone over 5% ownership threshold) and the S13G filings? I haven't seen those filings indicate anything but an increase in shares of approx 8M each from 2005 to 2006. I confess that I haven't done all the DD to see how many warrants they have rights to and might have converted in 2006 or to date in 2007, but from the SG filings, unless they had rights to more than 16M (8M each) in warrants for calander 2006, then they didn't sell ANY shares in 2006 contrary to what so many here post day after day.

They would only be guilty of converting warrants to shares and thus dilutint the share value by increasing the outstanding shares but unless they had the ability to convert more than 16M shares in 2006, that S13G filing would prove that they haven't sold any. Can anyone clarify that for me better, or if not, I suppose I can do the legwork to find out the specifics of all their warrant conversion rights.

Thanks in advance.

Share
New Message
Please login to post a reply